Market Research Logo

Pharmacovigilance (PV) and Drug Safety Software Market to 2027 - Global Analysis and Forecasts By Software Type ( Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software ); Delivery Mode ( On-premi

Pharmacovigilance (PV) and Drug Safety Software Market to 2027 - Global Analysis and Forecasts By Software Type ( Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software ); Delivery Mode ( On-premise, Cloud-based ); End User ( Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Pharmacovigilance Service Providers ),and Geography

Pharmacovigilance (PV) And Drug Safety Software Market to 2027 – Global Analysis and Forecasts by Software Type, Delivery Mode, End User, and Geography
The global pharmacovigilance (PV) and drug safety software market is expected to reach US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The pharmacovigilance (PV) and drug safety software market is estimated to grow with a CAGR of 6.4% from 2019-2027.
The market is driven by factors such as, rising incidences of adverse drug reactions (ADRs) and globalization of pharmacovigilance. However, expensive technology may limit the growth of the market to a certain extent.
The pharmacovigilance (PV) and drug safety software are used to recognize the cause of drug withdrawal and helps to inhibit unnecessary future events. These software are beneficial to those involved in drug making process like clinical research organization and pharmaceutical companies. These software help companies to manage huge data generated due to adverse drug reaction events. Help to maintain data for regulatory inspection and approval. These software lets global information to be shared rapidly and economically.
Though there are many advantages of pharmacovigilance (PV) and drug safety software the software deployment cost is expensive. Large pharma companies having good infrastructure for pharmacovigilance process in house prefer for on-premise. These require huge capital upfront. Hence, high price for installation of pharmacovigilance (PV) and drug safety software is anticipated to hinder the growth of market.
Global pharmacovigilance (PV) and drug safety software market was segmented by software type, delivery mode and end user. The software type was segmented as fully integrated software, adverse event reporting software, drug safety audits software, and issue tracking software. By delivery mode it is categorized in on-premise and cloud based. By end user contract research organizations (CRO’s), pharmaceutical and biotech companies, business process outsourcing.
Some of the major primary and secondary sources included in the report are, Drug Safety and Effectiveness Network, European Medicines Agency, Food and Drug Administration, National Adverse Drug Event Monitoring Centre, National Center for Biotechnology Information, Pharmacovigilance Program of India, World Health Organization, Canadian Institutes of Health Research, Indian Council of Medical Research, Federation of Pharmaceutical Industries and Associations among others.


1. Introduction1.1 Scope of the Study1.2 The Insight Partners Research Report Guidance1.3 Market Segmentation
1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Software Type1.3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Delivery Mode1.3.3 Global Pharmacovigilance (PV) and Drug Safety Software Market – By End User1.3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Geography
2. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Takeaways
3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research
4. Global Pharmacovigilance (PV) and Drug Safety Software Market – Market Landscape4.1 Overview4.2 PEST Analysis
4.2.1 North America PEST Analysis4.2.2 Europe PEST Analysis4.2.3 Asia Pacific PEST Analysis4.2.4 Middle East & Africa PEST Analysis4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
5. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Industry Dynamics5.1 Key Market Drivers
5.1.1 Rising Incidences Of Adverse Drug Reactions (ADRs5.1.2 Globalization Of Pharmacovigilance
5.2 Key Market Restraints
5.2.1 Expensive Technology
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence In Pharmacovigilance
5.5 Impact Analysis
6. Pharmacovigilance (PV) and Drug Safety Software Market – Global Analysis6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis6.3 Performance of Key Players
7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis– by Software Type7.1 Overview7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2018 & 2027 (%)7.3 Adverse Event Reporting Software Market
7.3.1 Overview7.3.2 Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Drug Safety Audits Software
7.4.1 Overview7.4.2 Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Issue Tracking Software
7.5.1 Overview7.5.2 Global Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Fully Integrated Software
7.6.1 Overview7.6.2 Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by Delivery Mode8.1 Overview8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2018 & 2027 (%)8.3 On-premise Market
8.3.1 Overview8.3.2 Global On-premise Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cloud- Based Market
8.4.1 Overview8.4.2 Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)
9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by End User9.1 Overview9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User 2018 & 2027 (%)9.3 Pharmaceutical and Biotech Companies Market
9.3.1 Overview9.3.2 Global Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Contract Research Organizations (CROs) Market
9.4.1.1 Overview9.4.1.2 Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Business Process Outsourcing (BPO) Firms Market
9.5.1 Overview9.5.2 Global Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)
10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis10.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.1.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.1.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.1.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.1.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)10.1.4 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.5 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.6 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.1.6.1 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.1.6.2 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.1.7 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.7.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.8 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.1.8.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.1.8.2 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.1.9 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.9.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.1.10 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.1.10.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.1.10.2 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.3.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.2.3.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.2.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)10.2.5 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.6 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.7 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.7.1 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.2.7.2 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.2.8 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.8.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.9 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.9.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.2.9.2 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.2.9.3 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.10 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.11 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.11.1 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.2.11.2 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.2.12 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.12.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.13 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.13.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.2.13.2 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.2.14 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.15 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.2.16 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.2.16.1 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.2.16.2 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.3.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.3.2.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.3.2.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.3.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)10.3.4 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.5 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.6 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.3.6.1 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.3.6.2 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.3.6.3 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.7 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.8 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.3.8.1 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.3.8.2 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.3.9 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.10 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.11 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.3.11.1 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.3.11.2 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.3.12 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.13 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.14 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.3.14.1 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.3.14.2 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.3.15 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.16 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.3.17 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.3.17.1 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.3.17.2 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.4.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.4.2.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.4.2.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.4.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)10.4.4 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.5 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.6 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.4.6.1 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.4.6.2 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.4.7 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.7.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.8 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.4.8.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.4.8.2 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.4.9 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.10 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.4.11 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.4.11.1 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.4.11.2 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5 South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.5.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.5.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.5.3 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.5.3.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.5.3.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.5.4 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)10.5.5 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.5.6 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.5.7 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.5.7.1 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.5.7.2 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)10.5.8 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.5.9 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)10.5.10 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)10.5.10.1 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)10.5.10.2 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
11. Pharmacovigilance (PV) and Drug Safety Software Market –Industry Landscape11.1 Overview11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-201911.3 Organic Developments
11.3.1 Overview11.3.2 Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019
11.4 Inorganic Developments
11.4.1 Overview11.4.2 Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019
12. Pharmacovigilance (PV) and Drug Safety Software Market–Key Company Profiles12.1 AB Cube
12.1.1 Key Facts12.1.2 Business Description12.1.3 Financial Overview12.1.4 Product Portfolio12.1.5 SWOT Analysis12.1.6 Key Developments
12.2 UNITED BIOSOURCE LLC
12.2.1 Key Facts12.2.2 Business Description12.2.3 Financial Overview12.2.4 Product Portfolio12.2.5 SWOT Analysis12.2.6 Key Developments
12.3 ArisGlobal LLC
12.3.1 Key Facts12.3.2 Business Description12.3.3 Financial Overview12.3.4 Product Portfolio12.3.5 SWOT Analysis12.3.6 Key Developments
12.4 Sparta Systems
12.4.1 Key Facts12.4.2 Business Description12.4.3 Financial Overview12.4.4 Product Portfolio12.4.5 SWOT Analysis12.4.6 Key Developments
12.5 Oracle
12.5.1 Key Facts12.5.2 Business Description12.5.3 Financial Overview12.5.4 Product Portfolio12.5.5 SWOT Analysis12.5.6 Key Developments
12.6 Sarjen Systems Pvt. Ltd
12.6.1 Key Facts12.6.2 Business Description12.6.3 Financial Overview12.6.4 Product Portfolio12.6.5 SWOT Analysis12.6.6 Key Developments
12.7 EXTEDO
12.7.1 Key Facts12.7.2 Business Description12.7.3 Financial Overview12.7.4 Product Portfolio12.7.5 SWOT Analysis12.7.6 Key Developments
12.8 ENNOV
12.8.1 Key Facts12.8.2 Business Description12.8.3 Financial Overview12.8.4 Product Portfolio12.8.5 SWOT Analysis12.8.6 Key Developments
12.9 Maxapplication
12.9.1 Key Facts12.9.2 Business Description12.9.3 Financial Overview12.9.4 Product Portfolio12.9.5 SWOT Analysis12.9.6 Key Developments
12.10 Online Business Applications, Inc.
12.10.1 Key Facts12.10.2 Business Description12.10.3 Financial Overview12.10.4 Product Portfolio12.10.5 SWOT Analysis12.10.6 Key Developments
13. Appendix13.1 About The Insight Partners13.2 Glossary Of Terms
LIST OF TABLES
Table 1. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 2. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 3. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 4. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 5. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 6. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 7. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 8. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 9. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 10. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 11. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 12. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 13. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 14. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 15. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 16. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 17. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 18. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 19. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 20. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 21. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 22. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 23. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 24. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 25. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 26. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 27. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 28. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 29. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 30. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 31. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 32. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 33. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 34. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 35. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 36. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 37. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 38. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 39. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 40. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 41. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 42. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 43. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 44. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 45. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 46. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 47. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 48. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 49. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 50. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 51. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 52. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 53. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 54. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 55. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 57. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 58. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 59. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 60. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 61. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 62. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 63. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 64. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 65. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 66. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 67. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 68. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 69. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 70. Recent Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
Table 71. Recent Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
Table 72. Glossary of Terms, Pharmacovigilance (PV) and Drug Safety Software Market
LIST OF FIGURES
Figure 1. Pharmacovigilance (PV) and Drug Safety Software Market Segmentation
Figure 2. Pharmacovigilance (PV) and Drug Safety Software Market Segmentation, by Region
Figure 3. Global Pharmacovigilance (PV) and Drug Safety Software Market Overview
Figure 4. Adverse Event Reporting Software Segment Held Largest Share Of The Software Type Segment In Pharmacovigilance (PV) and Drug Safety Software Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography (US$ Mn)
Figure 7. Global Pharmacovigilance (PV) and Drug Safety Software Market- Leading Country Markets (US$ Mn)
Figure 8. Global Pharmacovigilance (PV) and Drug Safety Software Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Driver and Restraints Pertaining to Pharmacovigilance (PV) and Drug Safety Software Market
Figure 15. Global Pharmacovigilance (PV) and Drug Safety Software Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 16. Global Pharmacovigilance (PV) and Drug Safety Software Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 17. Prominent Players in the Pharmacovigilance (PV) and Drug Safety Software Market
Figure 18. Global Pharmacovigilance (PV) and Drug Safety Software Market, by Product & Services 2018 & 2027 (%)
Figure 19. Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report